Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letters to Editor
  • Published:

Induction of Long Term Lymphocyte Lines from Delayed Hypersensitive Human Donors using Specific Antigen plus Epstein–Barr Virus

Abstract

THE availability of homogeneous populations of human and murine myeloma cells has provided a unique opportunity for investigating the mechanism of immunoglobulin formation1. Continuous lines of cultured lymphoid cells producing specific antibody or manifesting delayed hypersensitivity would be even more useful in studying the molecular events of the immune response. Human lymphoid cell lines have been established in long term culture using Epstein–Barr virus (EBV)2, 3 or phyto-haemagglutinin4 but antigen alone has not been effective5. The purpose of the work reported here was selectively to establish antigen-sensitive cells in culture by stimulating peripheral white cells from delayed hypersensitive donors with antigen in vitro and then exposing the cells to EBV. This combination of antigen and virus was chosen because of the following considerations: (1) some RNA and DNA viruses do not replicate in resting lymphocytes but can infect antigen-sensitive lymphocytes which have been stimulated in vitro with mitogens or specific antigen6, 7; (2) polyoma virus transforms cells in the G2 phase of the cell cycle more effectively than in G1 (ref. 8). These observations suggested that combined exposure to antigen and EBV might result in the establishment of cell lines enriched for antigen-sensitive or antibody-forming cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Scharff, M. D., and Lascov, R., Prog. Allergy, 29, 577 (1970).

    Google Scholar 

  2. Pope, J. H., Home, M. K., and Scott, W., Intern. J. Cancer, 3, 857 (1968).

    Article  CAS  Google Scholar 

  3. Gerber, P., Whang-Peng, J., and Marroe, J. H., Proc. US Nat. Acad. Sci., 63, 740 (1969).

    Article  Google Scholar 

  4. Broder, S. W., Glade, P. R., and Hirschhorn, K., Blood, 35, 539 (1970).

    CAS  PubMed  Google Scholar 

  5. Choi, K. W., and Bloom, A. D., Nature, 227, 171 (1970).

    Article  CAS  Google Scholar 

  6. Nahmias, A. H., Kilbrick, S., and Rosan, R. C., J. Immunol., 93, 68 (1964).

    Google Scholar 

  7. Bloom, B., Jiminez, L., and Marcus, P., J. Exp. Med., 132, 16 (1970).

    Article  CAS  Google Scholar 

  8. Basilico, C., and Marin, G., Virology, 28, 429 (1966).

    Article  CAS  Google Scholar 

  9. Fahey, J. L., Finegold, I., Rabson, A. S., and Manaker, R. A., Science, 152, 1259 (1966).

    Article  CAS  Google Scholar 

  10. Tanigaki, N., Yago, Y., Moore, G. E., and Pressman, D., J. Immunol., 97, 634 (1966).

    CAS  PubMed  Google Scholar 

  11. Lascov, R., and Scharff, M. D., J. Exp. Med., 131, 515 (1970).

    Article  Google Scholar 

  12. Maizel, J. V., jun., Science, 151, 988 (1966).

    Article  CAS  Google Scholar 

  13. Scharff, M. D., Shapiro, A. L., and Ginsberg, B., Cold Spring Harbor Symp. Quant. Biol., 32, 223 (1967).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BAUMAL, R., BLOOM, B. & SCHARFF, M. Induction of Long Term Lymphocyte Lines from Delayed Hypersensitive Human Donors using Specific Antigen plus Epstein–Barr Virus. Nature New Biology 230, 20–21 (1971). https://doi.org/10.1038/newbio230020a0

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1038/newbio230020a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing